Skip to main content
Current Health Sciences Journal logoLink to Current Health Sciences Journal
. 2020 Dec 31;46(4):405–411. doi: 10.12865/CHSJ.46.04.12

Analysis of Prostate Adenocarcinoma Histopathological Types in Relation to Tumor Grade

ANDREI PĂNUŞ 1, CRISTIANA EUGENIA SIMIONESCU 2, PETRU OCTAVIAN DRĂGOESCU 3, PAUL TOMESCU 3, ALEX EMILIAN STEPAN 2
PMCID: PMC7948024  PMID: 33717516

Abstract

Prostate adenocarcinomas are some of the most common malignancies diagnosed in men, and the evaluation of tumor growth patterns is the basis for establishing the aggressiveness of the lesions. The study included 283 cases of prostate adenocarcinomas for which histopathological type and tumor grade were analyzed. The results indicated the association of ductal, sarcomatoid and signet ring-like cell types with aggressive growth patterns and high scores, atrophic and pseudohyperplastic types with mild growth patterns and low scores, foamy gland type presented intermediate growth patterns/scores, while conventional and colloid types had variable aspects. The grading systems used may be considered consistent with the histological types of prostate adenocarcinomas.

Keywords: Prostate adenocarcinoma, histological type, Gleason score

Introduction

Prostate adenocarcinomas are common lesions in men's oncological pathology, ranking second after bronchopulmonary carcinoma [1].

Although the mortality rate from prostate cancer is relatively low compared to other malignancies, the aspect can only be discussed in the case of localized disease in which 5-year survival is about 100% and decreases to 30% in extensive and metastatic lesion [2].

In this context, prostate adenocarcinoma is expected to become the main malignant lesion of men in the coming years, with an incidence rate of 21%, compared to lung cancer with a rate of around 13% [2,3]. On the contrary, there are other studies projecting a decrease in the incidence of prostate cancer, especially due to the relatively wide access to screening programs on PSA (prostate-specific antigen) serum assessment, a decrease that could be affected due to population aging and increased incidence in patients under 50 years of age [4].

Thus, there is a permanent concern for improving the histopathological criteria for reporting prostate adenocarcinomas, which include the parameters of aggression of the lesions being directly related to the prognosis and therapeutic attitude, including tumor type, grade and stage. Although the grading systems of prostate adenocarcinomas have improved in the last 50 years, there are still some problems related to reproducibility, the reporting of tumor heterogeneity or the prognostic significance of growth sub-patterns [5,6,7,8,9].

In this study, the histopathological type of prostate adenocarcinomas was analyzed in relation to the grading systems of the lesions.

Material and Methods

This study included 283 prostate adenocarcinomas diagnosed during five years (2016-2020) in the Pathology Department of the Emergency County Hospital of Craiova. The biological material was represented by fragments of prostate biopsy (186 cases) and fragments of tumor transurethral resection (TURp) (97 cases) from patients who were first admitted to the Urology Clinic of the same hospital. The tumor fragments were fixed in 10% buffered neutral formalin and routinely processed for classical paraffin embedding and Hematoxylin-Eosin staining. All tumors analyzed were classified and graded according to indications of the WHO (World Health Organization) working group for tumors of the urinary system and male genital organs [10].

The inclusion criteria in the study were the diagnosis of prostate adenocarcinoma in patients who had no history of urological pathology or oncological history of any kind.

The statistical analysis used the chi square (χ2) comparison tests within SPSS 10 software. For images acquisition was used the Nikon Eclipse E600 microscope equipped with Lucia 5 software. The study was approved by the Ethical Committee of The University of Medicine and Pharmacy of Craiova, and all patients gave a written informed consent regarding the publication of these data.

Results

The study included 283 patients with prostate adenocarcinoma with a mean diagnostic age of 72.6±10.2 years. Analysis of the tumor histological type indicated the net predominance of conventional acinar carcinomas diagnosed in 200 cases, which represented 70.7% of the casuistry. Depending on the degree of differentiation, the tumor architecture was glandular, cribriform or solid.

In general, the tumor glands were small/medium, irregular, infiltrative, with rigid lumen, lined with atypical cuboidal-columnar cells and the absence of the basal layer, separated by a variable amount of stroma, sometimes with glandular fusions and accentuated pleomorphism (Figure 1A).

Figure 1.

Figure 1

Prostate adenocarcinoma, HE staining, x200. A. Conventional type; B. Atrophic type; C. Pseudohyperplastic type; D. Foamy cell type; E. Colloid type; F. Signet-ring like cells type; G. Sarcomatoid type; H. Ductal type

Atrophic and pseudohyperlastic acinar adenocarcinomas were identified in 6 cases, each representing 2.1% of the analyzed group. The atrophic type was usually mixed with conventional areas, with well-represented glands, some dilated and lined with flattened epithelia, while the pseudohyperplastic type showed a papillary glandular pattern with back-to-back pattern, with a distorted and anastomized appearance (Figures 1, B-C).

Foamy gland adenocarcinoma was identified in 31 cases, being second in frequency and representing 11%, tumor cells presenting abundant clear vacuolated cytoplasm, sometimes with acidophilic granules (Figure 1D).

The colloid type (mucinous) was present in 13 cases (4.6%), in which we found accumulations of extracellular mucinous secretion in over 25% of the tumor volume (Figure 1E).

The tumor type signet ring-like cells consisted in the presence of tumor cells with vacuolated cytoplasm and peripheral nucleus, an aspect observed in 4 cases (1.4%), while the sarcomatoid type consisted in the presence of slightly elongated tumor cells arranged fasciculately in a desmoplastic stroma, aspect identified in 6 cases (2.1%) (Figure 1 F-G).

In the case of ductal adenocarcinoma identified in 17 cases (6%) the tumor areas were solid, papillary or cribriform, sometimes with central comedo necrosis (Figure 1H).

The analysis of tumor growth patterns indicated the predominance of mixed patterns present in 108 cases (38.2% of cases), followed by pattern 3 in 95 cases (33.6%), pattern 4 in 29 cases (10.2%) and pattern 5 in 51 cases. 18%). The pure growth pattern 3 was characterized by the presence of groups of individualized infiltrative glands with malignant characters, the pure pattern 4 by the presence of fused glands, sometimes with compact or cribriform appearance, while the pure pattern 5 presented solid architecture or infiltrative cell cords (Figures 2A, 2B, 2C, 2D).

Figure 2.

Figure 2

Prostate adenocarcinoma, HE staining, x100. A. Growth pattern 3; B. Growth pattern 4; C. Growth pattern 5; D. Mixed pattern

In the mixed tumor growth, pattern 3 was present in 83 cases, pattern 4 in 82 cases and pattern 5 in 51 cases.

The analysis of growth patterns in relation to tumor type indicated statistically significant association of conventional, atrophic, hypertrophic and foamy gland types with pattern 3, ductal type with pattern 4 and colloid, signet ring-like cells and sarcomatoid types with pattern 5 (p<0.001, χ2 test) (Table 1)

Table 1.

Distribution of cases depending on histologic type and tumoral growth pattern

Histologic type/Growth pattern

Pattern 3

Pattern 4

Pattern 5

Mixed

Conventional

63

20

35

82

Atrophic

6

-

-

-

Pseudohyperplastic

6

-

-

-

Foamy gland

20

-

-

11

Colloid

-

1

3

9

Signet ring-like cells

-

-

4

-

Sarcomatoid

-

-

6

-

Ductal

-

8

3

6

Analysis of Gleason scores indicated the predominance of score 6 (95 cases, 33.6%), followed by the frequency of score 7 (57 cases, 20.2%), score 8 (55 cases, 19.4%), score 10 (51 cases, 18%) and score 9 (25 cases, 8.7%). In relation to the histological type, scores 6-8 were associated with the conventional type, score 6 with atrophic and pseudohyperplastic types, score 6-7 with foamy gland type, scores 9-10 with sarcomatoid and signet ring-like cells, aspects that were statistically significant (p<0.001, χ2 test) (Table 2)

Table 2.

Distribution of cases depending on histologic type and classic Gleson score

Histologic type/ Classic Gleason score

Gleason 6

Gleason 7

Gleason 8

Gleason 9

Gleason 10

Conventional

63

44

44

14

35

Atrophic

6

-

-

-

-

Pseudohyperplastic

6

-

-

-

-

Foamy gland

20

11

-

-

-

Colloid

-

2

3

5

3

Signet ring-like cells

-

-

-

-

4

Sarcomatoid

-

-

-

-

6

Ductal

-

-

8

6

3

At the same time we found the association of atrophic and pseudohyperplastic types with simplified grade group 1, of the foamy gland type with groups 1-2 and of the ductal, sarcomatoid and signet ring-like cells types with groups 4-5, statistically significant aspects (p<0.001, χ2 test) (Table 3).

Table 3.

Distribution of cases depending on histologic type and simplified grading groups

Histologic type/ Simplified Gleason score

Grade group 1

Grade group 2

Grade group 3

Grade group 4

Grade group 5

Conventional

63

27

17

44

49

Atrophic

6

-

-

-

-

Pseudohyperplastic

6

-

-

-

-

Foamy gland

20

6

5

-

-

Colloid

-

2

-

3

8

Signet ring-like cells

-

-

-

-

4

Sarcomatoid

-

-

-

-

6

Ductal

-

-

-

8

9

Statistical analysis of histopathological types of prostate adenocarcinomas in relation to the degree of tumor differentiation indicated the concordance of tumor growth pattern with classic Gleason score and simplified grading scores and indicated a well differentiated appearance of atrophic and pseudohyperplastic types, predominantly moderately differentiated for foamy gland type. and predominantly poorly differentiated for ductal, sarcomatoid, and signet ring-like cell types, while conventional and colloidal types revealed varying degrees of differentiation.

Discussions

Histological variants of prostate adenocarcinomas have prognostic and therapeutic significance.

There are studies that have shown an excellent prognosis for the atrophic, pseudohyperplastic, foamy glands and microcystic types, while the signet ring-like cell, pleomorphic, sarcomatoid types are associated with a reserved prognosis [11].

Invasive ductal carcinoma is frequently associated with conventional types, accounting for approximately 5% of prostate carcinomas.

The atrophic type is most often graded as pattern 3 and can be identified sporadically after hormonal treatments or radiotherapy, while the pseudohyperplastic type can simulate papillary hyperplasia being classified with the same pattern [11,12].

Foamy gland type is in almost 20% of cases being mixed with conventional areas and is graded with pattern 3 or 4 although there may be higher Gleason scores [11,12].

Colloid adenocarcinoma is characterized by Gleason scores frequently ranging from 6-8, this type not being as aggressive as indicated in the past [13].

Signet ring-like cell type is designated as having pattern 5, and sarcomatoid type (carcinosarcoma) is a biphasic tumor in patients with a history of radiation therapy or hormone therapy [11,12].

The results obtained in our study are largely consistent with those in the literature and even if for some types gradation is not indicated, the appearance was reported on account of the associated conventional tumor areas.

The most common types were conventional adenocarcinomas (70.7%), followed by foamy gland type (11%), colloid type (4.6%), atrophic/pseudohyperplastic and sarcomatoid types (2.1%), signet ring-like cell type (1.4%) while the ductal type was identified in 6% of cases.

The Gleason grading system is one of the oldest and most effective pathological and clinical tools successfully in clinical practice and in relation to patient prognosis [9].

The grading systems of prostate adenocarcinomas have been in a permanent dynamic which has led to some changes over time, so that they can be directly associated with the prognosis, be reproducible and be representative of the entire tumor volume even if the degree is set on biopsy fragments [8,9,14,15,16,17].

The grading system for prostate adenocarcinomas was introduced by Broders A in 1926 and had four grades, and later in 1966 Gleason DF introduced a grading system based on five growth patterns observed in tumors, which was later adopted worldwide [14,18,19].

The International Society of Urological Pathologists (ISUP) in 2005 made some changes to the original Gleason gradation, including poorly defined or large cribriform tumor glands assigned to grade 4, well-defined glands or small cribriform ones to grade 3, and in the case of biopsies to be including grades 4 and 5 even when the percentage was below 5% [8,16,17,20].

Subsequently, patterns 1 and 2 were removed from the Gleason score in the case of biopsies and TURP, being considered without prognostic importance [14,21].

At the same time, the specialized studies indicated prognostic differences of the reporting of the primary pattern 3 or 4 within the Gleason 7 score [22].

In addition, some issues remained after 2005 related to the reproducibility of the Gleason score which was unsatisfactory [5].

In 2013, five simplified (prognostic) grading groups are proposed, respectively group 1 (Gleason≤6), 2 (Gleason 7=3+4), 3 (Gleason 7=4+3), 4 (Gleason 8) and 5 (Gleason 9 and 10), which were subsequently recommended by the WHO and the American Joint Committee on Cancer (AJCC) [23,24].

Currently, the intraobserver reproducibility rate for the Gleason score varies up to 80%, while the interobserver rate has a maximum of 81% according to the new grading criteria [16].

In this study, the association of the histological type with both the growth pattern and the classic and simplified Gleason grading was analyzed.

The Gleason system is entirely based on tumor growth patterns. Individual growth patterns are not usually specified in pathological reports, although they appear to have an independent predictive value [25].

In our study, the conventional and colloid histological types were associated with variable Gleason scores/Gleason grade groups, atrophic and pseudohyperplastic types to low scores/groups, foamy gland type to intermediate scores/groups and signet ring-like cell, sarcomatoid and ductal types to high scores/groups. In addition to the advantages related to the reproducibility and superior prognostic concordance of the new grading system, there are still disadvantages.

Thus, in addition to the loss of tumor heterogeneity assessment, the Sehn JK et al. emphasizes in 2018 these aspects that refer to the fact that tertiary patterns were excluded and group grading cannot be applied in these cases, there is no limit of prognostic significance for the percentage of pattern 4 in score 7, the cribriform pattern seems more aggressive compared with the glomeruloid one or with glands fused within the score 8 and the fact that there are other histological criteria (fibroplasia, the percentage of paternal 5 in the score 8) which are associated with a worse prognosis and which are not taken into account during gradation [9].

However, nowadays the Gleason grading system is an important parameter for the prognosis and treatment of prostate adenocarcinomas, being associated with biochemical values, local recurrence, localized/metastatic disease and the type of therapeutic attitude [9,17].

Conclusions

The results indicated the prostate adenocarcinomas of ductal, sarcomatoid and signet ring-like cell types as associated with aggressive patterns and high scores, foamy cell type associated with intermediate categories and atrophic and pseudohyperplastic types with low categories, while for conventional and colloidal lesions the aspects were variable.

The study indicated the usefulness of tumor growth pattern and classical and simplified grading systems for assessing the aggressiveness of different histological types of prostate adenocarcinomas, in the context of the statistical concordance of these parameters.

Conflict of interests

None to declare.

References

  • 1.Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi: 10.3322/caac.21208. [DOI] [PubMed] [Google Scholar]
  • 2.Printz C. Prostate cancer mortality projections reach a new high: With prostate cancer deaths projected to rise to their highest level in 20 years, some experts worry that changes to screening guidelines made in 2012 could be a factor. Cancer. 2020;126(17):3893–3894. doi: 10.1002/cncr.33127. [DOI] [PubMed] [Google Scholar]
  • 3.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi: 10.3322/caac.21590. [DOI] [PubMed] [Google Scholar]
  • 4.Carioli G, Bertuccio P, Boffetta P, Levi F, La Vecchia C, Negri E, Malvezzi M. European cancer mortality predictions for the year 2020 with a focus on prostate cancer. Ann Oncol. 2020;31(5):650–658. doi: 10.1016/j.annonc.2020.02.009. [DOI] [PubMed] [Google Scholar]
  • 5.Egevad L, Mazzucchelli R, Montironi R. Implications of the International Society of Urological Pathology modified Gleason grading system. Arch Pathol Lab Med. 2012;136(4):426–434. doi: 10.5858/arpa.2011-0495-RA. [DOI] [PubMed] [Google Scholar]
  • 6.Samaratunga H, Delahunt B, Yaxley J, Srigley JR, Egevad L. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. Scand J Urol. 2016;50(5):325–329. doi: 10.1080/21681805.2016.1201858. [DOI] [PubMed] [Google Scholar]
  • 7.Kweldam CF, Wildhagen MF, Steyerberg EW, Bangma CH, van der Kwast TH, van Leenders GJ. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod Pathol. 2015;28(3):457–464. doi: 10.1038/modpathol.2014.116. [DOI] [PubMed] [Google Scholar]
  • 8.Berney DM, Beltran L, Fisher G, North BV, Greenberg D, Møller H, Soosay G, Scardino P, Cuzick J. Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome. Br J Cancer. 2016;114(10):1078–1083. doi: 10.1038/bjc.2016.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sehn JK. Prostate Cancer Pathology: Recent Updates and Controversies. Mo Med. 2018;115(2):151–155. [PMC free article] [PubMed] [Google Scholar]
  • 10.Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon, France: International Agency for Research on Cancer; 2016. [Google Scholar]
  • 11.Humphrey PA. Histopathology of Prostate Cancer. Cold Spring Harb Perspect Med. 2017;7(10):a030411–a030411. doi: 10.1101/cshperspect.a030411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shah RB, Zhou M. Prostate biopsy interpretation: an illustrated guide. Berlin Heidelberg: Springer-Verlag; 2012. [Google Scholar]
  • 13.Marcus DM, Goodman M, Jani AB, Osunkoya AO, Rossi PJ. A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008. Prostate Cancer Prostatic Dis. 2012;15(3):283–288. doi: 10.1038/pcan.2012.4. [DOI] [PubMed] [Google Scholar]
  • 14.Kweldam CF, van Leenders GJ, van der Kwast T. Grading of prostate cancer: a work in progress. Histopathology. 2019;74(1):146–160. doi: 10.1111/his.13767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Böcking A, Kiehn J, Heinzel-Wach M. Combined histologic grading of prostatic carcinoma. Cancer. 1982;50(2):288–294. doi: 10.1002/1097-0142(19820715)50:2<288::aid-cncr2820500220>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  • 16.Chen N, Zhou Q. The evolving Gleason grading system. Chin J Cancer Res. 2016;28(1):58–64. doi: 10.3978/j.issn.1000-9604.2016.02.04. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Barakzai MA. Prostatic Adenocarcinoma: A Grading from Gleason to the New Grade-Group System: A Historical and Critical Review. Asian Pac J Cancer Prev. 2019;20(3):661–666. doi: 10.31557/APJCP.2019.20.3.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Broders A. Carcinoma grading and practical application. Arch Pathol Lab Med. 1926;2:376–381. [Google Scholar]
  • 19.Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50(3):125–128. [PubMed] [Google Scholar]
  • 20.Epstein JI, Allsbrook WC, Amin MB, Egevad LL, ISUP Grading Committee The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29(9):1228–1242. doi: 10.1097/01.pas.0000173646.99337.b1. [DOI] [PubMed] [Google Scholar]
  • 21.Berney DM. The case for modifying the Gleason grading system. BJU Int. 2007;100(4):725–726. doi: 10.1111/j.1464-410X.2007.07036.x. [DOI] [PubMed] [Google Scholar]
  • 22.Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Giovannucci EL, Rubin MA, Mucci LA. Gleason score and lethal prostate cancer: does 3+4=4+3. J Clin Oncol. 2009;27(21):3459–3464. doi: 10.1200/JCO.2008.20.4669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pierorazio PM, Walsh PC, Partin AW, Epstein JI. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int. 2013;111(5):753–760. doi: 10.1111/j.1464-410X.2012.11611.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Epstein JI. Prostate cancer grading: a decade after the 2005 modified system. Mod Pathol. 2018;31(S1):S47–63. doi: 10.1038/modpathol.2017.133. [DOI] [PubMed] [Google Scholar]
  • 25.van Leenders GJLH, Verhoef EI, Hollemans E. Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading. Histopathology. 2020;77(6):850–861. doi: 10.1111/his.14214. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Current Health Sciences Journal are provided here courtesy of Editura Medicală Universitară

RESOURCES